Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,612.82
(
-0.18%
)
US TECH 100
23,734.40
(
-0.26%
)
Dow Jones
46,114.09
(
-0.24%
)
Brent Oil
103.40
(
-2.98%
)
Bitcoin
70,446.84
(
-1.12%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 163196

Saturday, 06/29/2013 4:41:32 PM

Saturday, June 29, 2013 4:41:32 PM

Post# of 257259

ABBV’s ABT-450-based regimen uses ritonavir at half the normal PK-boosting dose; if this regimen were using ritonavir at full strength, it would be much more of a detriment to commercial uptake.





Perhaps you are more qualified to answer McBio's question. Is there enough hard data on the efficacy of ABT-450 in combination with PegRiba? If so which drug (in your opinion) appears superior?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now